Anders Olof Adolf Ekblom
Vorsitzender bei XSPRAY PHARMA AB
Vermögen: 15 334 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Anders Olof Adolf Ekblom
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Karolinska Institutet
95
| College/University | Other Consumer Services | 95 |
| Public Company | Biotechnology | 33 | |
| Public Company | Biotechnology | 31 | |
28
| Public Company | Pharmaceuticals: Major | 28 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
19
| Subsidiary | Miscellaneous Commercial Services | 19 |
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
9
| Holding Company | Biotechnology | 9 |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden.
7
| Holding Company | Packaged Software | 7 |
Modul 1 Data AB
 Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden.
7
| Subsidiary | Information Technology Services | 7 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.
7
| Subsidiary | Investment Managers | 7 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Vetenskapsrådet
3
| Private Company | 3 | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Forska Sverige
 Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services.
2
| Private Company | Miscellaneous Commercial Services | 2 |
XSpray Pharma Futurum AB
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anders Olof Adolf Ekblom
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Graduate Degree | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Chief Operating Officer Comptroller/Controller/Auditor | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Investment Committee Member Chief Executive Officer Director/Board Member Private Equity Investor | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Founder Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| Chalmers University of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Graduate Degree | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Prokarium Ltd.
 Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Investor Relations Contact Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Stockholm | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
| MEDA AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Director/Board Member | |
| Medivir Personal AB | Director/Board Member Director/Board Member Director/Board Member | ||
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Koncentra Holding AB
 Koncentra Holding AB Investment ManagersFinance Koncentra Holding AB operates as an investment holding company. It is a privately held investment company with a focus on long-term investments within a range of different industries. The company was founded in 1999 and is headquartered in Stockholm, Sweden. | Investment Managers | Chairman Comptroller/Controller/Auditor | |
Recip AB
 Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CALMARK SWEDEN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Sigrid Therapeutics AB
 Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Medical Specialties | Director/Board Member Founder | |
LEO Laboratories Ltd.
 LEO Laboratories Ltd. Medical DistributorsDistribution Services Part of LEO Fondet, LEO Laboratories Ltd. is a British dermatology company that aims to improve the lives of people living with a dermatological condition. The company is based in Hurley, UK. LEO Laboratories supplies treatments to people with medical needs in more than 130 countries around the world and strives to positively impact the lives of 125 million people through medical dermatology by 2025. Founded in 1960 and headquartered in Denmark, the company currently employs 6,000 professionals across 60 countries. | Medical Distributors | Chief Executive Officer Director/Board Member | |
| TOBII DYNAVOX AB | Packaged Software | Chairman Director/Board Member | |
SymCel AB
 SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Director/Board Member |
Statistik
International
| Schweden | 40 |
| Vereinigtes Königreich | 8 |
| Vereinigte Staaten | 4 |
| Israel | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 8 |
| Finance | 4 |
| Health Services | 2 |
Operativ
| Director/Board Member | 654 |
| Corporate Officer/Principal | 215 |
| Chairman | 205 |
| Independent Dir/Board Member | 142 |
| Chief Executive Officer | 89 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Anders Olof Adolf Ekblom
- Unternehmensverbindungen
